Abstract
Pregnancy is characterized by a progressive increase in the different components of the renin angiotensin system (RAS) including angiotensin II, a potent vasoconstrictor. Pregnant women and experimental animals are resistant to the pressor e fect of increased angiotensin II concentrations during pregnancy. In normal pregnancy, maternal blood pressure (BP) begins to fall in early gestation, reaches a nadir in midgestation, and then gradually increases to nonpregnant levels before term in both humans and C57BL/6J mice. The mechanism producing these changes is unknown. The present study investigates the roles of angiotensin II subtype receptors (AT1a and AT2) in hemodynamic regulation during pregnancy in mice. Female mice genetically or pharmacologically manipulated to alter angiotensin receptor stimulation were bred to 2 strains of males. Maternal BP was measured daily throughout pregnancy. Pup weight and number were determined. Pregnancy-induced hypertension was apparent in transgenic female mice expressing the human angiotensin gene bred with males expressing human renin. This e fect was not apparent in the absence of the AT1a receptor (ie, in AT1a knockout mice). The midgestation BP decline in both C56BL/6J and AT1a(—/—) females was abolished by AT2 receptor antagonism. There was a linear, inverse relationship between average BP throughout pregnancy and the average pup weight and number per litter. In summary, these findings suggest that activation of the AT2 receptor may be an important factor in promoting the midgestation BP decline that occurs in several mammalian species and, furthermore, that angiotensin is an important modulator of BP during pregnancy.
Similar content being viewed by others
References
Robson SC, Hunter S., Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060–H1065.
Hytten F. Blood volume changes in normal pregnancy. Clin Haematol. 1985;14:601–612.
Gant NF, Daley GL, Chand S., Whalley PJ, MacDonald PC A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682–2689.
Clapp JF III, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol. 1997;80:1469–1473.
Halligan A., O’Brien E., O’Malley K., et al. Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J Hypertens. 1993;11:869–873.
Butz GM, Davisson RL Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics. 2001;5:89–97.
Hefler LA, Tempfer CB, Moreno RM, O’Brien WE, Gregg AR Endothelial-derived nitric oxide and angiotensinogen: blood pressure and metabolism during mouse pregnancy. Am J Physiol Regul Integr Comp Physiol. 2001;280:R174–R182.
Magness RR, Gant NF Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension. Semin Perinatol. 1994;18:45–69.
Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205–251.
Bottari SP, De GM, Steckelings UM, Levens NR Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol. 1993;14:123–171.
Csikos T., Gallinat S., Unger T. Extrarenal aspects of angiotensin II function. Eur J Endocrinol. 1997;136:349–358.
Peach MJ Molecular actions of angiotensin. Biochem Pharmacol. 1981;30:2745–2751.
Ito M., Oliverio MI, Mannon PJ, et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521–3525.
Munzenmaier DH, Greene AS Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 1996;27:760–765.
Scheuer DA, Perrone MH Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol. 1993;264:R917–R923.
Siragy HM, Carey RM The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′-, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996;97:1978–1982.
Gohlke P., Pees C., Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349–355.
August P., Lenz T., Ales KL, et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol. 1990;163:1612–1621.
Brown MA, Nicholson E., Gallery ED Sodium-renin-aldosterone relations in normal and hypertensive pregnancy. Br J Obstet Gynaecol. 1988;95:1237–1246.
Nasjletti A., Masson GM Studies on angiotensinogen formation in a liver perfusion system. Circ Res. 1972;31:(9 suppl 20):187–220.
Glorioso N., Atlas SA, Laragh JH, Jewelewicz R., Sealey JE Prorenin in high concentrations in human ovarian follicular fluid. Science. 1986;233:1422–1424.
Howard RB, Pucell AG, Bumpus FM, Husain A. Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology. 1988;123:2331–2340.
Baker PN, Broughton PF, Symonds EM Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond). 1990;79:403–408.
Chesley LC, Talledo E., Bohler CS, Zuspan FP Vascular reactivity to angiotensin II and norepinephrine in pregnant women. Am J Obstet Gynecol. 1965;91:837–842.
Sigmund CD, Jones CA, Kane CM, Wu C., Lang JA, Gross KW Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res. 1992;70:1070–1079.
Takimoto E., Ishida J., Sugiyama F., Horiguchi H., Murakami K., Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996; 274:995–998.
Merrill DC, Thompson MW, Carney CL, et al. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047–1055.
Daugherty A., Manning MW, Cassis LA Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol. 2001;134: 865–870.
Sugaya T., Nishimatsu S., Tanimoto K., et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995;270:18719–18722.
Kaiser JR, Cox BE, Roy TA, Rosenfeld CR Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression. Am J Physiol. 1998;274:R797–R807.
Tufro-McReddie A., Johns DW, Geary KM, et al. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol. 1994;266: F911–F918.
Carey RM Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension. 2005;45:840–844.
Bernstein KE, Alexander RW Counterpoint: molecular analysis of the angiotensin II receptor. Endocr Rev. 1992;13: 381–386.
Siragy HM, Carey RM Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension. 1999;33:1237–1242.
Arensa IA, Xu Y., Davidge ST Expression of angiotensin II type II receptors in the systemic microvasculature of women with normal and preeclamptic pregnancies. J Soc Gynecol Investig. 2005;12(2 suppl):p150A.
Suarez C., az-Torga G., Gonzalez-Iglesias A., Cristina C., Becu-Villalobos D. Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia. Am J Physiol Endocrinol Metab. 2004;286:E786–E794.
Bird IM, Mason JI, Rainey WE Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology. 1994;134:2468–2474.
Hein L., Meinel L., Pratt RE, Dzau VJ, Kobilka BK Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11:1266–1277.
Oliverio MI, Kim HS, Ito M., et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A. 1998;95:15496–15501.
Zahradka P., Yau L., Lalonde C., et al. Modulation of the vascular smooth muscle angiotensin subtype 2 (AT2) receptor by angiotensin II. Biochem Biophys Res Commun. 1998;252:476–480.
Bonnet F., Cooper ME, Carey RM, Casley D., Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens. 2001;19: 1075–1081.
Ouali R., Berthelon MC, Begeot M., Saez JM Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms. Endocrinology. 1997;138:725–733.
Shanmugam S., Llorens-Cortes C., Clauser E., Corvol P., Gasc JM Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol. 1995;268:F922–F930.
Armando I., Jezova M., Juorio AV, et al. Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol. 2002;283:F934–F943.
Baiardi G., Macova M., Armando I., Ando H., Tyurmin D., Saavedra JM Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept. 2005;124:7–17.
Krishnamurthi K., Verbalis JG, Zheng W., Wu Z., Clerch LB, Sandberg K. Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA. Endocrinology. 1999;140: 5435–5438.
Wu Z., Maric C., Roesch DM, Zheng W., Verbalis JG, Sandberg K. Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. Endocrinology. 2003;144:3251–3261.
Siragy HM, Carey RM The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264–269.
Siragy HM, Jaffa AA, Margolius HS, Carey RM Renin-angiotensin system modulates renal bradykinin production. Am J Physiol. 1996;271:R1090–R1095.
Tsutsumi Y., Matsubara H., Masaki H., et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925–935.
Carey RM, Wang ZQ, Siragy HM Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 2000;35:155–163.
Siragy HM, Inagami T., Ichiki T., Carey RM Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506–6510.
Merrill DC, Karoly M., Chen K., Ferrario CM, Brosnihan KB Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine. 2002;18:239–245.
Valdes G., Neves LA, Anton L., et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006;27:200–207.
Saito T., Ishida J., Takimoto-Ohnishi E., et al. An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J. 2004;18:388–390.
Churchill D., Perry IJ, Beevers DG Ambulatory blood pressure in pregnancy and fetal growth. Lancet. 1997;349:7–10.
Himmelmann K., Himmelmann A., Niklasson A., Svensson A. Hypertension in pregnancy and size at birth. Blood Press. 1996;5:278–284.
Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 1997;18:613–621.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, K., Merrill, D.C. & Rose, J.C. The Importance of Angiotensin II Subtype Receptors for Blood Pressure Control During Mouse Pregnancy. Reprod. Sci. 14, 694–704 (2007). https://doi.org/10.1177/1933719107309060
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719107309060